The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19

Conditions:   Coronavirus Disease 2019;   Novel Coronavirus Pneumonia Intervention:   Drug: T89 Sponsor:   Tasly Pharmaceuticals, Inc. Not yet recruiting

Source: ClinicalTrials.gov - February 26, 2020 Category: Research Source Type: clinical trials